Role of Routine hs-Troponin and CRP Pre-Operatively for Non-Cardiac Surgery
Routine preoperative hs-troponin measurement is recommended in intermediate- and high-risk patients undergoing high-risk non-cardiac surgery, while routine preoperative CRP measurement has limited evidence and is not currently recommended for standard perioperative cardiac risk assessment.
Preoperative High-Sensitivity Troponin
When to Measure Preoperatively
Obtain preoperative hs-troponin in patients with:
- Baseline cardiovascular risk >5% for death or MI at 30 days 1
- RCRI score ≥1 1
- Age 45-64 years with significant cardiovascular disease 1
- Age ≥65 years 1
- Elevated NT-proBNP/BNP before surgery 1
- Undergoing high-risk non-cardiac surgery 2
The 2023 European Society of Cardiology guidelines specifically recommend documenting troponin preoperatively in intermediate- and high-risk patients undergoing high-risk surgery 2. This baseline value is critical for interpreting postoperative elevations, as approximately 41% of high-risk patients have detectable preoperative hs-troponin >14 ng/L 3.
Prognostic Value of Preoperative Troponin
Elevated preoperative hs-troponin independently predicts adverse outcomes:
- Postoperative MI risk: 3.67-fold increased odds when preoperative hs-troponin >14 ng/L 3
- Short-term mortality: 5.39-fold increased risk 4
- Long-term mortality: 2.17-2.90-fold increased hazard 3, 4
- 3-year mortality: 25% vs 11% in patients with elevated vs normal preoperative hs-troponin 3
Adding preoperative hs-troponin to clinical risk models improves the C-statistic by 0.058-0.109, demonstrating meaningful enhancement of risk stratification 4.
Postoperative Troponin Surveillance
The most important recommendation is postoperative, not just preoperative, troponin monitoring. The 2017 Canadian Cardiovascular Society guidelines provide a strong recommendation (moderate-quality evidence) to obtain daily troponin measurements for 48-72 hours after surgery in elevated-risk patients 1. This is based on the landmark VISION study (N=15,133) showing that 65% of perioperative MIs are asymptomatic and would go undetected without routine surveillance 1.
Key evidence supporting postoperative surveillance:
- Myocardial injury after noncardiac surgery (MINS) occurs in 8% of patients 1
- MINS increases 30-day mortality from 1.1% to 9.8% 1
- 84% of MINS patients remain asymptomatic 1
- Postoperative troponin is the strongest predictor of 30-day mortality 1
Guideline Divergence
There is notable divergence between North American and European guidelines versus the 2014 ACC/AHA guidelines:
2014 ACC/AHA position 5: States routine postoperative troponin screening "provides a non-specific assessment of risk, does not indicate a specific course of therapy, and is not clinically useful outside of the patient with signs or symptoms." This guideline predates the VISION study's full impact and awaited the MANAGE trial results.
2017 Canadian guidelines 1: Provide a strong recommendation for routine postoperative troponin surveillance in elevated-risk patients, based on the VISION study and subsequent validation.
2023 ESC guidelines 2: Include preoperative troponin documentation as a quality indicator for intermediate- and high-risk patients.
2026 AHA/ACC guidelines 6: Recommend serial troponin measurement in elevated-risk patients, acknowledging that elevated postoperative troponin identifies patients at >20% risk of cardiac events.
The more recent guidelines (2017-2026) reflect evolved understanding that MINS detection, even without definitive treatment protocols, allows for intensified medical management and closer monitoring that may improve outcomes 6.
Preoperative C-Reactive Protein (CRP)
Current Evidence
Routine preoperative CRP measurement is NOT recommended in current major perioperative guidelines 1, 5, 2, 7. None of the ACC/AHA, Canadian Cardiovascular Society, or ESC perioperative guidelines include CRP as a recommended preoperative biomarker.
Limited Supporting Evidence
One prospective cohort study (N=2,054) found that preoperative CRP predicted perioperative major cardiovascular events 8:
- Optimal cut-off: 3.4 mg/L
- Relative risk of highest vs lowest quartile: 3.7 (p<0.001)
- Adding CRP to RCRI improved adjusted RR from 1.5 to 4.6
However, this single-center study has not been validated in larger multicenter trials or incorporated into guideline recommendations. CRP is a non-specific inflammatory marker that lacks the specificity needed for routine perioperative cardiac risk assessment 9.
When CRP Might Be Considered
CRP may have utility in specific contexts:
- Postoperative atrial fibrillation risk: One recent study showed preoperative hs-CRP predicted POAF after thoracoscopic surgery, improving C-statistic from 0.758 to 0.845 10
- Sepsis differentiation: In critically ill patients, CRP combined with procalcitonin may help distinguish sepsis-induced cardiomyopathy from other causes of myocardial injury 9
These remain investigational applications, not standard practice.
Practical Algorithm
Preoperative Assessment
Step 1: Risk Stratification
- Calculate RCRI score
- Assess surgical risk (low, intermediate, high)
- Consider age and cardiovascular disease burden
Step 2: Biomarker Testing
Measure preoperative hs-troponin if:
- RCRI ≥1, OR
- Age 45-64 with significant CVD, OR
- Age ≥65, OR
- Elevated NT-proBNP/BNP, OR
- Undergoing high-risk surgery
Do NOT routinely measure CRP (insufficient evidence)
Step 3: Postoperative Surveillance
- Measure troponin daily for 48-72 hours postoperatively in the same elevated-risk patients 1
- Obtain baseline within 24 hours, then at 48 hours minimum 2
- Continue surveillance even in asymptomatic patients
Interpreting Results
Preoperative hs-troponin elevation (>14 ng/L for most assays):
- Indicates 2-5 fold increased risk
- Warrants enhanced perioperative monitoring
- Consider cardiology consultation for optimization
- Ensure maximal guideline-directed medical therapy
Postoperative troponin elevation (MINS):
- Obtain cardiology consultation 6
- Intensify cardiovascular medical therapy 6
- Consider aspirin and statin if not already prescribed 6
- Close postoperative monitoring
- Patient education about MINS diagnosis 6
Common Pitfalls
Measuring troponin only when symptomatic: 65% of perioperative MIs are asymptomatic 1
Not obtaining baseline preoperative value: Without baseline, cannot determine if postoperative elevation is acute or chronic 6, 11
Stopping surveillance at 24 hours: Most MIs occur within 48 hours; surveillance should continue 48-72 hours 1
Dismissing modest elevations: Even troponin 14-20 ng/L carries 1.1% 30-day mortality vs 0.01-0.05% with normal values 11
Assuming elevated troponin requires no action: While optimal management is still being defined, cardiology consultation and medical therapy intensification are associated with improved outcomes 6
Routine CRP measurement: Wastes resources without evidence-based benefit for perioperative cardiac risk assessment